Abstract CN11
Background
Patients with prostate cancer may experience a worsening in their emotional wellbeing and physical health due to treatments or disease burden. It has been reported that physical activity and lifestyle interventions are associated with improved patient outcomes and a lack of health literacy is perceived by patients as a key burden of their cancer experience, and an improvement in this aspect has been strongly correlated with better overall survival. Voice assistants have emerged as a promising tool to support patients' guided learning and exercises. Here, we report on the development, content, and functionality of the first Amazon Alexa voice assistant for patients living with prostate cancer in Spain.
Methods
A multidisciplinary group of expert physicians on prostate cancer were selected as a scientific committee. Based on their clinical experience and the scientific evidence, the working group agreed on and created the content. The topics for each module were defined through the use of a consensus technique. The digital skill, named ProstaGYM, was endorsed by the national patient association ANCAP and the design and programming was performed by an Amazon developer with support from Bayer Hispania.
Results
The skill contains four content modules: 1) general disease information and healthy lifestyle recommendations, 2) exercise routines to prevent sarcopenia, 3) specific exercises and interventions to manage urinary symptoms, 4) advice on sexual health and psychological support. ProstaGYM is available free of charge on the Spain Amazon Alexa skill store. Since its launch in November 2022, the following information on metrics were obtained (cut-off 30th April 2023): 144 unique customers, 164 user enablements (skill activation) and 182 sessions.
Conclusions
The skill ProstaGYM constitutes an innovative approach to guide patients with prostate cancer to self-manage disease symptoms and treatment side effects and promote physical exercise that may improve their quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Bayer Hispania.
Funding
Bayer Hispania.
Disclosure
E. Gallardo: Financial Interests, Institutional, Speaker, Consultant, Advisor, Grant support, Travel/accomodation expenses: Sanofi, Janssen, Astellas, Bayer, Ipsen, Pfizer, Roche, Bristol Myers Squibb; Financial Interests, Institutional, Speaker, Consultant, Advisor: Novartis, EUSA Pharma, MSD, Merck, Rovi, Daiichi Sankyo, Techdow, Lilly, Advanced Accelerator Applications; Financial Interests, Institutional, Speaker, Consultant, Advisor, Travel/Accomodation expenses: Eisai, AstraZeneca; Financial Interests, Institutional, Research Grant, Grant support: Ferrer; Financial Interests, Institutional, Other, Travel/Accomodation expenses: Pierre Fabre. D. Büchser Garcia: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Astellas, Janssen. L. Regis Placido: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Recordati. E. Rios Gonzalez: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Janssen, Recordati, Merck, AstraZeneca; Financial Interests, Institutional, Speaker’s Bureau: Astellas. A. Marco Perez, C. Moretones Agut: Non-Financial Interests, Institutional, Other, Employee: Bayer.
Resources from the same session
CN65 - Assessment of fatigue in elderly hospitalized cancer patients undergoing chemotherapy: A pilot study
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract
CN66 - Cancer symptom clusters, nutritional status and quality of life of patients with cancer undergoing outpatient chemotherapy
Presenter: Luis Carlos Lopes-Júnior
Session: Poster session 25
Resources:
Abstract
CN67 - Comparison of existing guidelines for healthcare professionals on the perceived symptoms of breast cancer patients with registered symptoms in the medical records: Preliminary results
Presenter: Trine Lund-Jacobsen
Session: Poster session 25
Resources:
Abstract
CN68 - Experiences and needs of rectal cancer survivors without or with minor low anterior resection syndrome
Presenter: Fien Serroyen
Session: Poster session 25
Resources:
Abstract
CN69 - Experiences of patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A qualitative study
Presenter: Jill Dobbelaer
Session: Poster session 25
Resources:
Abstract
CN70 - Out of hours symptom triage and supportive care
Presenter: Kate Mckendry
Session: Poster session 25
Resources:
Abstract
CN71 - SensiEx: A randomized pilot trial Sensorimotor training using whole body vibration exercise to reduce chemotherapy-induced peripheral neuropathy after treatment for breast cancer
Presenter: Malin Backman
Session: Poster session 25
Resources:
Abstract
CN72 - Symptom burden, quality of life and emotional status of patients with advanced lung cancer seen at the functional lung unit
Presenter: Isabel Brao Perez
Session: Poster session 25
Resources:
Abstract
CN73 - Symptom management in patients with chemotherapy-induced hand-foot syndrome: A qualitative study
Presenter: jie Zhang
Session: Poster session 25
Resources:
Abstract
CN74 - The effect of nursing senior's self-efficacy on symptom management in cancer patients on clinical decision-making skills
Presenter: Sevinç kutlutürkan
Session: Poster session 25
Resources:
Abstract